retatrutide ly3437943 glp-1 gip glucagon Retatrutide, a GIP, and receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA GLP-3 (R) - Triple GIP

Limit Processed and Sugary Foods You do not have to be perfect, but consistently high intake of ultraprocessed foods can slow your progress

Excessive weight regain means you spend weeks after restarting just getting back to where you were

A clinically significant interaction exists between tirzepatide and oral contraceptives, requiring backup contraception for 4 weeks after initiation and each dose increase, and patients taking levothyroxine or other time-sensitive medications warrant closer monitoring

SMAs provide an efficient format for comprehensive lifestyle education and peer support

For many people, digestive side effects are most noticeable early on and while the dose is being increased, and they tend to ease as the body adjusts

Shift from morning to evening, or vice versa